Please login to the form below

Not currently logged in
Email:
Password:

Shire set to make move for Cubist

Shire Pharmaceuticals is planning a takeover of US-based Cubist Pharmaceuticals in a multi-billion pound deal, according to a UK media report

Shire Pharmaceuticals is planning takeover of US-based Cubist Pharmaceuticals in a multi-billion pound deal, according to a UK media report.

An article in The Daily Telegraph claims industry rumours are suggesting that Shire approached Cubist about a month ago with a $44.5-a-share deal, and that the two companies have been in discussions since.

Shire, which acquired Advanced BioHealing last week in a £460m deal, is reported to be keen to expand as a way fending off potential bidders itself.

Cubist sells an antibiotic called Cubicin, which is used to treat complex skin infections and the superbug MRSA.

Speaking to PMLiVE, Shire said it declines to comment on industry speculation.

Cubist was available to comment at the time of writing.

24th May 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

What are you doing, Dave?
Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
Fake News is Bad for your Health
Ill informed patients make poor health decisions...
Secrets of Pharma Advertising
If the goal of branding is to be different, why do so many Pharma brand ads look the same?...

Infographics